Overview
Axios Biosciences is a company revolutionizing oncology drug discovery by identifying drugs active in the tumor microenvironment, an important component of biology where tumors interact with non-malignant cells. These interactions can greatly affect the sensitivity of tumors to drugs. Our unique technology and approach, published in the journal Nature Medicine, allows us to identify novel drugs that traditional drug discovery approaches miss.